Literature DB >> 29947473

Refractory pityriasis rubra pilaris with good response after treatment with ustekinumab.

Raquel Aragón-Miguel1, Marta Prieto-Barrios1, Alba Calleja-Algarra1, Virginia Velasco-Tamariz1, Juan José Andres-Lencina1, Pablo Ortiz-Romero2, Verónica Monsálvez-Honrubia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29947473     DOI： 10.1111/ddg.13550

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  2 in total

1.  A Case of Meningococcal and HSV-2 Meningitis in a Patient Being Treated with Ustekinumab for Pityriasis Rubra Pilaris.

Authors:  Charalampos I Kalogeropoulos; Konstantinos A Papathanasiou; Ismini Tsagkaraki; Georgios Giannopoulos; Aristotelis Bamias; Eleni I Boutati
Journal:  Eur J Case Rep Intern Med       Date:  2020-05-22

2.  Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.

Authors:  Dylan Haynes; Jennifer L Strunck; Christina A Topham; Alex G Ortega-Loayza; Gail Kent; Pamela B Cassidy; Ronghua Hu; Keith Choate; Zhiping Wang; Yuangang Liu; Teri M Greiling
Journal:  JAMA Dermatol       Date:  2020-06-01       Impact factor: 10.282
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.